April 30, 2010 Tags: None
WASHINGTON – A first-of-a-kind prostate cancer treatment that uses the body’s immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy. Dendreon Corp.‘s Provenge vaccine trains the immune system to fight tumors.
Read more
